Related Experiment Video
Updated: Jun 15, 2026

09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Pediatric angiosarcoma of soft tissue: a rare clinicopathologic entity
Lobna Ayadi1, Abdelmajid Khabir
1Department of Pathology, Habib Bourguiba University Hospital, Tunisia. ayadilobna@yahoo.fr
Archives of Pathology & Laboratory Medicine
|March 4, 2010
Summary
Childhood angiosarcomas are rare, aggressive vascular tumors primarily affecting the head, neck, and mediastinum. Diagnosis requires immunohistochemistry due to challenging pathology, and complete resection is crucial for localized cases.
Area of Science:
- Pediatric Oncology
- Vascular Tumors
- Surgical Pathology
Background:
- Angiosarcomas are rare malignant vascular tumors predominantly affecting adults.
- Childhood angiosarcomas are exceedingly rare, with limited understanding of their biology and natural history.
- These tumors often occur in the head, neck, and mediastinum and are typically high-grade.
Purpose of the Study:
- To review the limited literature on pediatric angiosarcomas.
- To highlight diagnostic challenges and the importance of immunohistochemistry.
- To discuss treatment considerations for this rare pediatric malignancy.
Main Methods:
- Literature review of pediatric angiosarcoma cases.
- Analysis of clinical presentation, pathology, and treatment outcomes.
- Emphasis on immunohistochemical markers for diagnosis.
Main Results:
- Childhood angiosarcomas are rare, aggressive, and often high-grade.
- Head and neck/mediastinum are common locations.
- Vasoformative features may be subtle, necessitating immunohistochemistry for diagnosis.
- Differential diagnoses include Kaposi sarcoma and other vascular tumors.
- Complete surgical resection is the recommended treatment for localized disease.
Conclusions:
- Pediatric angiosarcomas are aggressive malignant vascular tumors.
- Accurate diagnosis, often requiring immunohistochemistry, is critical.
- Complete resection is essential for localized tumors in children.
